CN Patent

CN121401211A — 一种双羟萘酸盐药物缓释微球及其制备方法

Assigned to Zhuhai Huahaikang Pharmaceutical Technology Co ltd · Expires 2026-01-27 · 0y expired

What this patent protects

本发明涉及一种双羟萘酸盐药物缓释微球及其制备方法。根据本发明的制备方法制备的注射用缓释微球制剂，微球粒度分布较窄、药物活性成分释放时间可以持续大约三个月至四个月。此外，通过本发明制备的微球制剂能在动物体内维持稳定的血药浓度，在三至四个月内没有较大的血药浓度波动，更好的避免了毒副作用的发生。

USPTO Abstract

本发明涉及一种双羟萘酸盐药物缓释微球及其制备方法。根据本发明的制备方法制备的注射用缓释微球制剂，微球粒度分布较窄、药物活性成分释放时间可以持续大约三个月至四个月。此外，通过本发明制备的微球制剂能在动物体内维持稳定的血药浓度，在三至四个月内没有较大的血药浓度波动，更好的避免了毒副作用的发生。

Drugs covered by this patent

triptorelin-pamoate (TRIPTORELIN PAMOATE)

Patent Metadata

Patent number: CN121401211A
Jurisdiction: CN
Classification: —
Expires: 2026-01-27
Drug substance claim: No
Drug product claim: No
Assignee: Zhuhai Huahaikang Pharmaceutical Technology Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.